CenterStar Asset Management’s Pfizer PFE Stock Holding History

CenterStar Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,600	Closed	-$326K	–	472
2026 Q1	$326K	Sell	11,600 -11,100	-49%	-$296K	0.04%	383
2025 Q4	$565K	Buy	+22,700	New	+$572K	0.16%	141
2023 Q2	–	Sell	-18,800	Closed	-$767K	–	363
2023 Q1	$767K	Buy	+18,800	New	+$812K	0.28%	74
2022 Q3	–	Hold	0	–	-$486K	–	455
2022 Q2	–	Hold	0	–	–	–	181
2022 Q1	–	Hold	0	–	–	–	116
2021 Q3	–	Hold	0	–	-$1.7M	–	746
2021 Q2	–	Hold	0	–	–	–	90
2021 Q1	–	Hold	0	–	–	–	104
2020 Q2	–	Hold	0	–	-$1K	–	859
2020 Q1	–	Hold	0	–	–	–	733
2019 Q3	–	Hold	0	–	-$3K	–	553
2019 Q2	–	Hold	0	–	–	–	294
2018 Q2	–	Hold	0	–	-$15K	–	1018
2018 Q1	–	Hold	0	–	–	–	767
2017 Q4	–	Hold	0	–	–	–	766

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CenterStar Asset Management's PFE Position: Q1 2026 in Review

CenterStar Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 9,156 shares — an estimated $244K sold.

CenterStar Asset Management first reported a position in PFE in Q2 2023 and held it in 2 quarters. The position peaked at $915K in Q2 2023. 2,963 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

CenterStar Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
CenterStar Asset Management sold 9,156 Pfizer shares in Q1 2026, an estimated $244K.
CenterStar Asset Management first reported a position in Pfizer in Q2 2023 and held it in 2 quarters.
CenterStar Asset Management's Pfizer position peaked at $915K in Q2 2023.
2,963 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on CenterStar Asset Management's 13F filing for Q1 2026, filed 1 May 2026.